 

Active ingredient: Amoxicillin 

 

Form/Route: Capsules/Oral 

 

Recommended studies: 2 studies 

 

1. Type of study: Fasting 

Design: single-dose, two-treatment, two-period, crossover in vivo 

Strength: 500 mg 

Subjects: Healthy males and non-pregnant females, general population. 

Additional Comments: 




________________________________________________________________ 

2. Type of study: Fed 

Design: single-dose, two-treatment, two-period, crossover in vivo 

Strength: 500 mg 

Subjects: Healthy males and non-pregnant females, general population. 

Additional Comments: 




________________________________________________________________ 

 

Analytes to measure (in appropriate biological fluid): Amoxicillin in plasma 

 

Bioequivalence based on (90% CI): Amoxicillin 

 

Waiver request of in-vivo testing: 250 mg based on (i) acceptable in vivo 
bioequivalence studies on the 500 mg strength, (ii) acceptable in vitro dissolution testing 
of all strengths, and (iii) proportional similarity of the formulations across all strengths. 

 

Dissolution test method and sampling times: 

 

Please conduct comparative dissolution testing on 12 dosage units of all strengths of the 
test and reference products using the methods specified in the current USP. 
Specifications will be determined upon review of the application. 

 

 

 

 

 

 


